Workflow
Health Equity
icon
Search documents
Tevogen Recognized in BINJE's BEST Health Care 2025 for Advancing Health Equity and Sustainable Biopharma
GlobeNewswire News Room· 2025-08-22 19:25
WARREN, N.J., Aug. 22, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc. (“Tevogen” or the “Company”) (Nasdaq: TVGN), announced today that it has been named in BINJE’s BEST Health Care 2025: Companies, Organizations and Service Providers. BINJE, a media outlet covering business and politics across New Jersey, highlighted Tevogen Bio’s Founder and CEO, Ryan Saadi, MD, MPH, for his commitment to health equity and innovation in sustainable biopharma. In its recognition, BINJE noted, “Driven by an unrelenting ...
Health equity expert calls Trump’s school fitness test plan ‘political theater’
MSNBC· 2025-08-03 17:33
[Music] Welcome back to Politics Nation. This week, President Trump signed an executive order to bring the presidential fitness test back to public school. The fitness test was first established by President Eisenhower in 1956.The original version called for students to complete 40 push-ups, 10 pull-ups, and a 6 and a half uh minute mile. Uh joining me now is Dr. . Usher Blackstock, CEO of Advancing Health Equity.Uh Doc, will help a as you know, I take my health uh and physical shape very seriously. I I hav ...
FDA head talks rebuilding the food pyramid and cracking down on ultra-processed foods
Yahoo Finance· 2025-07-31 16:19
Regulatory Transparency & Flexibility - The FDA emphasizes regulatory flexibility, tailoring processes to specific conditions, especially rare and incurable ones, considering limited alternatives [1][2] - Drug developers and pharmaceutical companies deserve predictability, as highlighted by the framework for COVID vaccine regulation published in the New England Journal of Medicine [4][5] - The FDA aims for transparency by releasing decision letters to the public and drug developers, modernizing the agency, and addressing misinformation, including rewriting dietary guidelines with USDA [12][13] Vaccine & Booster Recommendations - While the CDC sets the vaccine schedule, the FDA has approved vaccines for high-risk populations; booster shots for low-risk individuals require more research [5][6] - There are scientific unknowns and polarizing views regarding the necessity and frequency of COVID boosters, especially for healthy young individuals, alongside concerns about vaccine injuries [8][9] Public Trust & Misinformation - Public trust in health institutions has significantly declined, with trust in doctors and hospitals dropping from 71% to 40% in the last four years, necessitating rebuilding efforts [10][11] - The FDA is addressing misinformation by rewriting the food pyramid with USDA, ending the "war on natural saturated fat," and clarifying the difference between whole grains and ultra-processed foods [13] Food & Dietary Guidelines - The FDA is taking action to remove petroleum-based food dyes, inspired by previous discussions on removing "poisons and chemicals" from the food supply [17][18] - The FDA acknowledges the addictive nature of processed foods, designed by food scientists, contributing to chronic diseases and insulin resistance in children [20][21] - The SNAP program now has waivers for states to restrict taxpayer dollars from being used for junk food and sugary drinks [22] Women's Health - Women's health issues have been historically overlooked, prompting the FDA to host a roundtable on hormone replacement therapy for perimenopausal women [25][26] - The NIH is refocusing its funding to study root causes of chronic diseases, including school lunch programs, sleep medicine, and environmental exposures [29] Opioid Crisis & Supplements - The FDA, along with the DEA, is taking action to schedule 7-hydroxy mitragynine (7-OHM), a synthetic opioid found in vape stores, which is 13 times more potent than morphine [35][36] - The FDA is concerned about the unregulated nature of supplements and the need for regulation to ensure Americans are taking trustworthy and healthy products [33]
The Cigna Group Health Equity Impact Fund Opens 2025 Grants
Prnewswire· 2025-06-04 10:00
Core Viewpoint - The Cigna Group Foundation is allocating an additional $3 million from its Health Equity Impact Fund to support health equity initiatives in Hartford, Connecticut, and St. Louis, Missouri, focusing on addressing significant health disparities in these communities [1][2]. Group 1: Fund Allocation and Goals - The Health Equity Impact Fund will distribute a total of $3 million in grants this year, continuing its commitment to improving health outcomes in Hartford and St. Louis [1][2]. - The fund is part of a larger $9 million, three-year initiative, committing $3 million per grant cycle to support local organizations [2]. - Key program goals in Hartford include increasing access to primary care and transportation for adults facing health inequities [3][7]. - In St. Louis, the focus is on addressing high rates of substance use disorder and mental health challenges among residents [3][4]. Group 2: Grant Details - Nonprofits in both cities can apply for grants with terms of two years, with each grant amounting up to $250,000 [4]. - The Cigna Group Foundation has a history of impactful partnerships and previously announced a $27 million initiative over three years to support various health-related causes [5]. Group 3: Community Engagement - The Cigna Group Foundation aims to enhance culturally appropriate care, improve transportation access, and expand mental health services and substance use disorder treatment for adults in the targeted communities [7][9]. - The foundation's efforts are part of a broader strategy to address significant health challenges and improve access to care in areas of high need [9].
Health Net and Centene Foundation Invest More than $7.2 Million to Increase Patient Access to Care with Expanded Fleet of Mobile Clinics in California
Prnewswire· 2025-05-29 15:00
Core Insights - Health Net and the Centene Foundation announced a partnership investment exceeding $7.2 million to enhance healthcare services for underserved Californians through mobile health clinics [1][2] - The initiative aims to address barriers to care such as transportation issues and lost wages by providing essential preventive screenings and services directly to communities [2][3] Investment and Program Details - The funding is part of Health Net's new Mobile Outreach for Value, Equity and Sustainability (MOVES) program, which focuses on improving access to quality care in underserved areas [2][3] - Health Net has committed over $158 million in funding to community-based organizations from 2017 to 2024, reflecting a long-term investment in health equity and access [5][6] Community Impact - Mobile health clinics are designed to meet the healthcare needs of individuals in resource-limited areas, ensuring that those who require care are not overlooked [3][5] - The initiative aims to build sustainable care delivery models that foster trust between healthcare providers and communities, leading to better health outcomes [3][4] Grant Recipients and Collaborations - Grant recipients include organizations like AltaMed, Community Medical Centers, and Kaweah Health, which will use the funding to enhance their healthcare services [6][10] - The grants are intended to position these organizations as conveners, collaborating with local partners to address a wide range of physical, behavioral, and social needs [4]
2025年LSX世界大会的启示(英)2025
PitchBook· 2025-05-19 10:30
Investment Rating - The report indicates a positive outlook for European healthtech, highlighting a resilient venture capital funding environment and the emergence of consumer-focused healthtech unicorns [9][11]. Core Insights - The European healthtech sector is gaining momentum, particularly among consumer-focused companies, with notable unicorns like Cera, Huma, and Flo Health achieving a combined $430 million in venture funding [9]. - The overall venture capital funding in European and UK healthcare companies reached over $12.3 billion in 2024, marking the third-highest figure on record [11]. - The report emphasizes the importance of strategic partnerships between startups and large corporates, focusing on finding the right fit and developing meaningful return on investment metrics [8]. Summary by Sections Key Takeaways - Efficiency is a central theme, with companies aiming to achieve more with less, while large funding rounds may lead to inefficiencies [8]. - There is optimism regarding the potential for European companies to challenge US dominance in healthtech and life sciences, especially in light of shifting US trade policies [11]. Momentum for European Healthtech - The European venture ecosystem is forming the foundation for the next generation of consumer healthtech companies, contrasting with the US market's focus on B2B2C models [10]. - Notable funding rounds include Oura's $200 million round, elevating its valuation to $5.2 billion [9]. Spotlight on Women's Health - The report highlights the growing focus on women's health within the healthtech sector, although specific details are not provided in the extracted content. Appendix - The appendix includes a list of medtech startups showcased at the LSX World Congress, detailing their funding, valuations, and active investors [12][13].